2018
DOI: 10.1177/0269881118784876
|View full text |Cite
|
Sign up to set email alerts
|

The putative lithium-mimetic ebselen reduces impulsivity in rodent models

Abstract: These findings suggest that ebselen preferentially reduces motor impulsivity over choice impulsivity, and that inhibition of 5-HT receptor function is a contributing mechanism. Collectively, these data support the repurposing of ebselen as an anti-impulsive treatment and fast-tracking to clinical trials in patient groups characterised by poor impulse control.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
11
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 23 publications
(12 citation statements)
references
References 50 publications
1
11
0
Order By: Relevance
“…While the serotonin system is notoriously complex, comprising over 14 receptor subtypes (Barnes and Sharp, 1999), the 5-HT 2A and 5-HT 2c receptors play a prominent role in regulating impulsivity where they appear to play opposing roles. Antagonism of the 5-HT 2A receptor with M100 907 (Barkus et al, 2018; Fletcher et al, 2007, 2011; Nikiforuk et al, 2015; Winstanley et al, 2003, 2004b) or ketanserin (Fletcher et al, 2007; Passetti et al, 2003) or reducing 5-HT 2A function via ebselen (Barkus et al, 2018) reliably decreases premature responding on the 5-CSRTT. Similar reductions in impulsive action are observed following M100907 on the rodent gambling task (rGT): a decision-making task whose design is loosely based on the 5-CSRTT (Adams et al, 2017).…”
Section: Discussionmentioning
confidence: 99%
“…While the serotonin system is notoriously complex, comprising over 14 receptor subtypes (Barnes and Sharp, 1999), the 5-HT 2A and 5-HT 2c receptors play a prominent role in regulating impulsivity where they appear to play opposing roles. Antagonism of the 5-HT 2A receptor with M100 907 (Barkus et al, 2018; Fletcher et al, 2007, 2011; Nikiforuk et al, 2015; Winstanley et al, 2003, 2004b) or ketanserin (Fletcher et al, 2007; Passetti et al, 2003) or reducing 5-HT 2A function via ebselen (Barkus et al, 2018) reliably decreases premature responding on the 5-CSRTT. Similar reductions in impulsive action are observed following M100907 on the rodent gambling task (rGT): a decision-making task whose design is loosely based on the 5-CSRTT (Adams et al, 2017).…”
Section: Discussionmentioning
confidence: 99%
“…Although the mechanism behind this effect of 5-HT 2A receptor blockade is not certain, it may link to evidence of an inhibitory 5-HT 2A receptor-mediated feedback on 5-HT neurons (Sharp et al, 2007). Interestingly, the 5-HT 2A receptor has also been associated with impulse control; thus, selective 5-HT 2A receptor antagonists consistently decrease impulsivity in animal models (Winstanley et al, 2004;Winstanley, 2011;Barkus et al, 2018) and this is supported by psychopharmacological studies in humans using the non-selective 5-HT 2A receptor antagonist quetiapine (Rock et al, 2013). In this regard it is noteworthy that lithium and the repurposed lithium-mimetic ebselen are both reported to attenuate 5-HT 2A receptor function, likely via inhibition of the phosphoinositide pathway (Singh et al, 2013;Antoniadou et al, 2018).…”
Section: -Ht 2a Receptorsmentioning
confidence: 99%
“…Nevertheless, previous studies that investigated drugs that affect 5-HT 2A receptors have shown similar results to ours. Both M100907, a 5-HT 2A receptor specific antagonist, and the lithium-mimetic ebselen, known to dampen 5-HT 2A -related intracellular signaling, failed to show any effects on the rodent gambling task in rats (Adams et al, 2017;Barkus et al, 2018). Similar results on decision making behaviors together with psychedelic drugs have also been observed in humans.…”
Section: Discussionmentioning
confidence: 60%